The diabetic foot ulcers treatment market comprises medical devices and therapies to treat foot ulcers caused by diabetes. Poor blood circulation and nerve damage due to diabetes can cause foot ulcers which can become severely infected and potentially lead to amputation if left untreated. Wound care therapies help treat ulcers by promoting healing and preventing infections through regular dressing changes, offloading of pressure, and wound cleaning. Medical devices aid in preventing pressure ulcers through customized footwear and accommodative inserts. With rising diabetes prevalence worldwide, the need for effective ulcer treatment and preventive measures is increasing.
The Global Diabetic Foot Ulcers Treatment Market is estimated to be valued at US$ 7.72 Bn in 2024 and is expected to exhibit a CAGR of 10.% over the forecast period 2023 to 2030.
Key Takeaways
Key players operating in the Diabetic Foot Ulcers Treatment are 3M Healthcare, Braun Melsungen AG, Smith & Nephew, Inc., Organogenesis, Inc., Derma Sciences Inc., Sigvaris Inc., Acelity L.P. Inc., Osiris, Molnlycke Health Care AB, Alkem Laboratories Ltd., Healthium Medtech, Kerecis, Podimetrics, Carmell Corporation, Paracrine, Inc., VIVEX Biologics, Inc., and PolarityTE, Inc. The major players are focusing on new product launches and approvals to expand their product portfolio.
The growing prevalence of diabetes worldwide is a major factor augmenting the demand for diabetic foot ulcers treatment. According to International Diabetes Federation, approximately 643 million adults are expected to be living with diabetes by 2030. Regular screening and preventive care measures can help curb rising diabetes cases and foot complications.
Geographically, North America dominates the diabetic foot ulcers treatment market due to rapid adoption of advanced wound care therapies and medical devices. However, Asia Pacific is expected to witness highest growth over the forecast period owing to rising medical expenditures and increasing patient awareness in emerging nations like China and India.
Market Key Trends
The key trend gaining prominence in the diabetic foot ulcers treatment market is the ongoing shift towards preventive care approach. With diabetic foot complications posing a major healthcare burden, industry players are focusing on developing therapies, dressings and devices to prevent ulcer formation and reoccurrence. Research is also undergoing to better understand ulcer pathology and risk factors. This trend will help lower treatment costs and reduce amputation rates through early risk screening and ongoing patient education. Regular monitoring and management of modifiable risk factors will be crucial for long term preventive care.
Porter’s Analysis
Threat of new entrants: Low- High capital requirements due to research and developments. Bargaining power of buyers: High - Presence of many established products. Bargaining power of suppliers: Low - Availability of substitute products. Threat of new substitutes: High - Availability of alternative treatment options. Competitive rivalry: High - Large number of key players competing.
Geographical Regions
North America holds the highest market share in terms of value due to availability of advanced healthcare facilities and rising incidence of diabetes. Asia Pacific is expected to grow at the fastest CAGR during the forecast period owing to increasing healthcare expenditure and improving medical facilities in emerging economies like India and China.
Fastest Growing Region
Asia Pacific is projected to witness the highest growth rate during the forecast period. This is attributed to rising patient population, growing economy, increasing healthcare reforms, improving medical infrastructure, increasing healthcare expenditure, and rising awareness regarding diabetes treatment. Other factors such as rapidly changing lifestyle and lack of physical activities are also fueling the growth of the diabetic foot ulcers treatment market in this region.
No comments:
Post a Comment